Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Trust Co. of Vermont

Trust Co. of Vermont trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 13.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,851 shares of the company’s stock after selling 919 shares during the period. Trust Co. of Vermont’s holdings in Cardinal Health were worth $575,000 at the end of the most recent reporting period.

Several other institutional investors have also bought and sold shares of CAH. Clearstead Trust LLC bought a new stake in shares of Cardinal Health during the 4th quarter worth about $25,000. Raleigh Capital Management Inc. lifted its position in Cardinal Health by 4,466.7% in the fourth quarter. Raleigh Capital Management Inc. now owns 274 shares of the company’s stock worth $28,000 after purchasing an additional 268 shares during the period. YHB Investment Advisors Inc. bought a new position in Cardinal Health during the 1st quarter valued at $32,000. LRI Investments LLC bought a new position in Cardinal Health during the 1st quarter valued at $32,000. Finally, Palisade Asset Management LLC acquired a new position in shares of Cardinal Health during the 1st quarter valued at $34,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CAH shares. Robert W. Baird raised their target price on Cardinal Health from $129.00 to $130.00 and gave the company an “outperform” rating in a research note on Tuesday, July 9th. Wells Fargo & Company lowered their price objective on shares of Cardinal Health from $96.00 to $94.00 and set an “underweight” rating on the stock in a research note on Monday, April 29th. StockNews.com raised shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, July 22nd. Citigroup decreased their price target on shares of Cardinal Health from $115.00 to $107.00 and set a “neutral” rating on the stock in a research report on Friday, July 19th. Finally, Argus cut their price objective on Cardinal Health from $120.00 to $115.00 and set a “buy” rating for the company in a research report on Wednesday, May 15th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $109.67.

Cardinal Health Stock Up 1.2 %

Shares of NYSE:CAH traded up $1.16 during trading on Tuesday, reaching $99.52. 1,782,399 shares of the company traded hands, compared to its average volume of 2,150,915. The firm has a fifty day simple moving average of $98.57 and a 200 day simple moving average of $103.32. Cardinal Health, Inc. has a 1-year low of $85.11 and a 1-year high of $116.04. The firm has a market cap of $24.24 billion, a P/E ratio of 44.23, a price-to-earnings-growth ratio of 1.14 and a beta of 0.61.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.